MARLBOROUGH, Mass. & FREMONT, Calif.--(BUSINESS WIRE)--Cytyc Corporation (Nasdaq: CYTC), a leading provider of surgical and diagnostic products targeting women’s health and cancer diagnostics, and Xoft, Inc., a point of care radiation therapy company, announced a settlement to the intellectual property dispute involving the balloon based brachytherapy technologies developed by both companies for the treatment of breast cancer patients.
